Top Markets
Coin of the day
NeoImmuneTech, Inc. NeoImmuneTech, Inc.

NeoImmuneTech, Inc.

950220
Rang in aandelen #33508
As a clinical-stage biotechnology firm with a strong focus on T cells,... As a clinical-stage biotechnology firm with a strong focus on T cells, NeoImmuneTech, Inc. is dedicated to creating and marketing innovative immunotherapies. The company's lead product, NT-I7, is a long-acting human IL-7 currently in clinical development for its potential to treat a range of oncologic and infectious conditions. Founded in 2014, NeoImmuneTech is based in Rockville, Maryland.
Aandeelprijs
$1.12
Laatst gesynchroniseerd: 2026-08-14
Marktkapitalisatie
$7.52M
Verandering (1 dag)
4.51%
Verandering (1 jaar)
-94.79%
Land
US
Handel NeoImmuneTech, Inc. (950220)

Categorie

Koersgeschiedenis voor NeoImmuneTech, Inc. (950220)
Hoogste slotkoers: $1.08 op 2026-08-01

Laagste slotkoers: $301.12 op 2021-03-01
Koersgeschiedenis van NeoImmuneTech, Inc. van 2021 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -22.30%
2025 -38.71%
2024 -40.13%
2023 -56.86%
2022 -64.86%
2021 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$505.24 28.63%
US
$846.09 29.41%
NL
$734.04 6.81%
CH
$1.07K -6.40%
KR
$255.38 13.33%
BE